Journal article
Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccination
- Abstract:
- Recently, Liau et al. reported the results of Phase 3 clinical trial testing DCVax-L vaccines on patients with glioblastoma. Despite the promising and significant results obtained, the study design and the long-lasting period of recruitment of this work deserve some reflection
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 250.9KB, Terms of use)
-
- Publisher copy:
- 10.1038/s41416-023-02194-1
Authors
- Publisher:
- Springer Nature [academic journals on nature.com]
- Journal:
- British Journal of Cancer More from this journal
- Volume:
- 129
- Issue:
- 6
- Pages:
- 895-896
- Publication date:
- 2023-02-15
- DOI:
- EISSN:
-
1532-1827
- ISSN:
-
0007-0920
- Language:
-
English
- Keywords:
- Pubs id:
-
1330301
- Local pid:
-
pubs:1330301
- Source identifiers:
-
W4321002104
- Deposit date:
-
2026-05-05
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2023
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record